Morgan Stanley’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,901
Closed -$1K 6873
2020
Q1
$1K Sell
3,901
-95,951
-96% -$34.7K ﹤0.01% 6535
2019
Q4
$41K Buy
99,852
+56,395
+130% +$93.7K ﹤0.01% 5917
2019
Q3
$87K Buy
43,457
+33,825
+351% +$68.5K ﹤0.01% 5491
2019
Q2
$22K Sell
9,632
-3,628
-27% -$9.27K ﹤0.01% 5903
2019
Q1
$41K Buy
13,260
+103
+0.8% +$333 ﹤0.01% 5758
2018
Q4
$33K Sell
13,157
-11,823
-47% -$39.4K ﹤0.01% 5882
2018
Q3
$101K Buy
24,980
+2,955
+13% +$13K ﹤0.01% 5687
2018
Q2
$82K Buy
22,025
+17,106
+348% +$44.6K ﹤0.01% 5785
2018
Q1
$11K Sell
4,919
-8,671
-64% -$13.7K ﹤0.01% 6246
2017
Q4
$21K Buy
13,590
+11,490
+547% +$18.5K ﹤0.01% 6071
2017
Q3
$5K Sell
2,100
-10,040
-83% -$34.2K ﹤0.01% 6302
2017
Q2
$54K Sell
12,140
-7,360
-38% -$26.7K ﹤0.01% 5834
2017
Q1
$59K Sell
19,500
-13,203
-40% -$38.9K ﹤0.01% 5784
2016
Q4
$91K Buy
32,703
+1,007
+3% +$2.88K ﹤0.01% 5605
2016
Q3
$99K Buy
31,696
+6,441
+26% +$23.5K ﹤0.01% 5313
2016
Q2
$129K Buy
25,255
+20,203
+400% +$97.1K ﹤0.01% 5130
2016
Q1
$21K Sell
5,052
-12,773
-72% -$68.3K ﹤0.01% 5907
2015
Q4
$144K Sell
17,825
-16,232
-48% -$135K ﹤0.01% 5236
2015
Q3
$287K Buy
34,057
+8,596
+34% +$79.2K ﹤0.01% 4907
2015
Q2
$240K Buy
25,461
+2,996
+13% +$27.9K ﹤0.01% 5149
2015
Q1
$208K Buy
22,465
+8,077
+56% +$77.4K ﹤0.01% 5186
2014
Q4
$133K Sell
14,388
-1,800
-11% -$15.2K ﹤0.01% 5424
2014
Q3
$145K Sell
16,188
-26,645
-62% -$194K ﹤0.01% 5306
2014
Q2
$337K Buy
42,833
+24,917
+139% +$188K ﹤0.01% 4872
2014
Q1
$142K Sell
17,916
-1,236
-6% -$9.94K ﹤0.01% 5282
2013
Q4
$119K Buy
+19,152
New +$100K ﹤0.01% 5279